Geron Corporation (NASDAQ: GERN) is on The StockGuru Leader Board today. The stock is up as much as 5.80% on Friday.
Volume traded – so far – as this release was issued intraday: 393,409
Join in on the Discussion about GERN: http://members.stockguru.com/stocks/gern/
About the Company:
Geron Corporation, a biopharmaceutical company, develops therapies for cancer. The companys clinical development product candidates include Imetelstat, a telomerase inhibitor, which is in Phase II clinical trials for the treatment of metastatic breast cancer, advanced non-small cell lung cancer, thrombocythemia, and myeloma; and GRN1005, a lipoprotein receptor-related protein-1 directed peptide-drug conjugate that is used to transport paclitaxel, an anti-cancer drug in the blood brain barrier. Its GRN1005 clinical development product candidate is in Phase II clinical trials for the treatment of brain metastases arising from breast cancer; and brain metastases arising from non-small cell lung cancer. Geron Corporation was founded in 1990 and is based in Menlo Park, California.
About the StockGuru Leader Board:
We watch for stocks moving up and creating a positive momentum in the market. We are not compensated for coverage.
Feel free to suggest a stock for coverage if you see it breaking out. Contact: [email protected].
StockGuru.com
StockGuruCanada.com
Shareholdervision.com
BoldStocks.com
IR Affiliates – IRIR.co
StoneBridge Web & SEO – StonebridgeIQ.com